On Tuesday, Caribou Biosciences Inc (NASDAQ: CRBU) opened higher 6.83% from the last session, before settling in for the closing price of $1.61. Price fluctuations for CRBU have ranged from $0.66 to $3.54 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.41%. Company’s average yearly earnings per share was noted 3.38% at the time writing. With a float of $82.78 million, this company’s outstanding shares have now reached $93.47 million.
Caribou Biosciences Inc (CRBU) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Caribou Biosciences Inc is 11.44%, while institutional ownership is 37.01%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.
Caribou Biosciences Inc (CRBU) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.39 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.4) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.17% during the next five years compared to -33.41% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Check out the current performance indicators for Caribou Biosciences Inc (CRBU). In the past quarter, the stock posted a quick ratio of 5.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.70, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.42 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Looking closely at Caribou Biosciences Inc (NASDAQ: CRBU), its last 5-days average volume was 0.97 million, which is a jump from its year-to-date volume of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 52.09%.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 9.00%, which indicates a significant decrease from 87.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0828 in the past 14 days, which was lower than the 0.1632 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9229, while its 200-day Moving Average is $1.6389. However, in the short run, Caribou Biosciences Inc’s stock first resistance to watch stands at $1.7567. Second resistance stands at $1.7933. The third major resistance level sits at $1.8667. If the price goes on to break the first support level at $1.6467, it is likely to go to the next support level at $1.5733. Now, if the price goes above the second support level, the third support stands at $1.5367.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
There are currently 93,468K shares outstanding in the company with a market cap of 160.77 million. Presently, the company’s annual sales total 9,990 K according to its annual income of -149,110 K. Last quarter, the company’s sales amounted to 2,200 K and its income totaled -27,550 K.
